Oliveira dos Santos, David
Mohamed, Amir
Mohamed, Adam
Alvarenga, José Miguel
Torres, Tiago https://orcid.org/0000-0003-0404-0870
Funding for this research was provided by:
Universidade do Porto
Article History
Accepted: 14 December 2025
First Online: 14 January 2026
Declarations
:
: No funding was received for the preparation of this article.
: David Oliveira dos Santos, Amir Mohamed, Adam Mohamed, and José Miguel Alvarenga have no conflicts of interest that are directly relevant to the content of this article. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, and UCB.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All named authors (DOS, AM, AM, JMA, and TT) meet the International Committee of Medical Journal Editors criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given the final approval for the version to be published.